This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
2C-D: Difference between revisions
>Benzofury m A minor edit adding Brazilian law to the legal section with a official source. |
>Niamh Summary - initial investigations by Shulgin pre-date published synthesis / origin of name |
||
| Line 2: | Line 2: | ||
{{SubstanceBox/2C-D}} | {{SubstanceBox/2C-D}} | ||
'''2,5-dimethoxy-4-methylphenethylamine''' (also known as '''2C-M''', and more commonly as '''2C-D''') is a synthetic [[Psychoactive class::psychedelic]] of the [[Chemical class::phenethylamine]] chemical class that produces short-lived [[psychedelic]] effects comparable to those produced by [[mescaline]] and other [[2C-x]] compounds when [[routes of administration|administered]]. | '''2,5-dimethoxy-4-methylphenethylamine''' (also known as '''2C-M''', and more commonly as '''2C-D''') is a synthetic [[Psychoactive class::psychedelic]] of the [[Chemical class::phenethylamine]] chemical class that produces short-lived [[psychedelic]] effects comparable to those produced by [[mescaline]] and other [[2C-x]] compounds when [[routes of administration|administered]]. Its synthesis was first published in 1970 by a team from the Texas Research Institute of Mental Sciences,<ref>Amphetamine analogs. II. Methylated phenethylamines (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/5412084</ref>, but initial trials by [[Alexander Shulgin]] at sub-threshold doses were carried out in 1964. Further investigations at higher doses were carried out by Shulgin and his fellow researchers between 1974 and 1978.<ref>Shulgin, Alexander. "Pharmacology Lab Notes #1". Lafayette, CA. (1960-1976). p94, p175 (Erowid.org) | https://erowid.org/library/books_online/shulgin_labbooks/shulgin_labbook1_searchable.pdf</ref> The name '2C-D' derives from the chemical's structure - it is the 2-Carbon analogue of [[DOM]]. | ||
In his book [[PiHKAL]] ("Phenethylamines I Have Known And Loved"), Shulgin lists the dosage range as being from 20 to 60 mg, although now many people regard that as a conservative estimate as it has been learned that substantially higher doses can be taken to induce a full spectrum of classical psychedelic effects while still remaining physically benign, a quality that is unique in the 2C family (e.g. [[2C-P]], [[2C-T-7]]). Lower doses of 2C-D (generally 10 mg or less) have been explored for its use as a potential [[nootropic]], albeit with mixed results.<ref>Lemaire, D. (1990). Erowid 2C-D Vault: Smart Pills, by Hosten & Lazar. Retrieved from https://www.erowid.org/chemicals/2cd/2cd_smartpills1.shtml</ref> | In his book [[PiHKAL]] ("Phenethylamines I Have Known And Loved"), Shulgin lists the dosage range as being from 20 to 60 mg, although now many people regard that as a conservative estimate as it has been learned that substantially higher doses can be taken to induce a full spectrum of classical psychedelic effects while still remaining physically benign, a quality that is unique in the 2C family (e.g. [[2C-P]], [[2C-T-7]]). Lower doses of 2C-D (generally 10 mg or less) have been explored for its use as a potential [[nootropic]], albeit with mixed results.<ref>Lemaire, D. (1990). Erowid 2C-D Vault: Smart Pills, by Hosten & Lazar. Retrieved from https://www.erowid.org/chemicals/2cd/2cd_smartpills1.shtml</ref> | ||